SAFETY OF H-INFLUENZAE TYPE-B (HIB) CONJUGATE VACCINE (PRP-D) IN 15,713 CHILDREN 18-60 MONTHS OF AGE

被引：0

作者：

GREENBERG, DP

VADHEIM, CM

MARCY, SM

WARD, JI

机构：

[1] UNIV CALIF LOS ANGELES,LOS ANGELES CTY HARBOR MED CTR,SCH MED,DEPT MICROBIOL IMMUNOL,TORRANCE,CA 90509

[2] KAISER PERMANENTE,DEPT PEDIAT,PANORAMA CITY,CA

来源：

PEDIATRIC RESEARCH | 1989年 / 25卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

引用

页码：A179 / A179

页数：1

共 50 条

[41] SAFETY AND IMMUNOGENICITY OF HAEMOPHILUS-INFLUENZAE TYPE-B OLIGOSACCHARIDE-CRM-197 CONJUGATE VACCINE IN INFANTS AGED 15 TO 23 MONTHS
MADORE, DV
JOHNSON, CL
PHIPPS, DC
MYERS, MG
EBY, R
SMITH, DH
PEDIATRICS, 1990, 86 (04) : 527 - 534
[42] IMMUNOGENICITY OF PRP-TETANUS TOXOID CONJUGATE VACCINE (PRP-T) IN CHILDREN WITH SICKLE HEMOGLOBINOPATHY (SSA), MALIGNANCIES (MAL) OR FOLLOWING SYSTEMIC HAEMOPHILUS-INFLUENZAE TYPE-B (HIB) INFECTION
KAPLAN, SL
DUCKETT, T
MAHONEY, DH
SCHAFFER, DM
MASON, EO
PEDIATRIC RESEARCH, 1991, 29 (04) : A175 - A175
[43] IMMUNOGENICITY AND SAFETY OF 2 HAEMOPHILUS-INFLUENZAE TYPE-B CAPSULAR POLYSACCHARIDE VACCINES IN CHILDREN 18 AND 24 MONTHS OF AGE
GREENBERG, DP
BURKART, K
CHRISTENSON, PD
MARCY, SM
GURAVITZ, L
WARD, JI
CLINICAL RESEARCH, 1987, 35 (01): : A219 - A219
[44] CONCENTRATIONS OF ANTIBODY TO H-INFLUENZAE TYPE-B CAPSULAR POLYSACCHARIDE (PRP) 6-9 MONTHS AFTER RECEIVING PRP-N-MENINGITIDIS OUTER-MEMBRANE PROTEIN (PRP-OMP) VACCINE
SHAPIRO, ED
CAPOBIANCO, LA
BERG, AT
ZITT, MQ
PEDIATRIC RESEARCH, 1989, 25 (04) : A190 - A190
[45] IGG1 ANTIBODY-RESPONSES OF CHILDREN AND ADULTS IMMUNIZED WITH HEMOPHILUS-INFLUENZAE TYPE-B (HIB) POLYSACCHARIDE VACCINE (PRP)
GRANOFF, DM
SHACKELFORD, PG
BOIES, EG
MUNSON, RS
PEDIATRIC RESEARCH, 1985, 19 (04) : A294 - A294
[46] IMMUNOGENICITY AND REACTOGENICITY OF HAEMOPHILUS-INFLUENZAE TYPE-B - MENINGOCOCCUS GROUP-B OUTER-MEMBRANE PROTEIN CONJUGATE VACCINE IN CHILDREN 2-60 MONTHS OF AGE
SHEHAB, ZM
AZIMI, P
ASMAR, BI
DUNPHY, MG
AYOUB, EM
DAJANI, AS
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1991, 23 (06) : 763 - 769
[47] COST-BENEFIT-ANALYSIS OF HAEMOPHILUS-INFLUENZAE TYPE-B PREVENTION - CONJUGATE VACCINATION AT 18 MONTHS OF AGE
HAY, JW
DAUM, RS
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1990, 9 (04) : 246 - 252
[48] COMPARISON OF A COMBINATION ACELLULAR PERTUSSIS-COMPONENT DIPHTHERIA (D) AND TETANUS (T) TOXOID VACCINE (DTP-AC)/CONJUGATE HAEMOPHILUS-INFLUENZAE B(HIB) VACCINE (PRP-D) VS DTP-AC AND PRP-D AS SEPARATE INJECTIONS FOR THE 1ST BOOSTER IN 15-20 MONTH OLD CHILDREN
FELDMAN, S
ANDREW, M
CLINICAL RESEARCH, 1993, 41 (04): : A766 - A766
[49] Reactogenicity and safety of DTPa vaccine and Haemophilus influenzae type b conjugate vaccine (Hib) in a single injection vs DTPw and Hib as separate injections as a booster vaccination in 18-month-old children
Arístegui, J
García-Corbeira, P
de la Flor, J
Dal-Ré, R
Marés, J
Moraga, F
Campins, M
CLINICAL DRUG INVESTIGATION, 2001, 21 (01) : 9 - 16
[50] PROTEIN-OLIGOSACCHARIDE CONJUGATE VACCINE PRIMES INFANTS FOR A MATURE ANTIBODY (AB) RESPONSE TO THE CAPSULAR POLYSACCHARIDE (PRP) OF HEMOPHILUS-INFLUENZAE TYPE-B (HIB)
ANDERSON, PW
PICHICHERO, ME
PEDIATRIC RESEARCH, 1985, 19 (04) : A286 - A286

← 1 2 3 4 5 →